HekaBio

HekaBio K.K., founded in 2016 and based in Tokyo, Japan, specializes in the development, manufacturing, and sale of pharmaceutical products, medical devices, diagnostic tools, and regenerative medicine solutions. The company operates a bio venture platform focused on providing therapies for oncology and fibrotic diseases while also investing in global healthcare technology. HekaBio offers extensive expertise across various fields, including pharmaceuticals, medical devices, in-vitro diagnostics, digital health, and cell and gene therapies. This enables researchers to advance innovative programs and ensures that patients gain prompt access to cutting-edge healthcare advancements.